Mouse chromosome engineering for modeling human disease

Annual Review of Genomics and Human Genetics

Volumn 7, Issue , 2006, Pages 247-276

  Van Der Weyden, Louise ^a   Bradley, Allan ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Chromosome rearrangement; Copy number change; loxP; Mouse model

Indexed keywords

CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CHROMOSOME INSERTION; CHROMOSOME INVERSION; CHROMOSOME MUTATION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; DIGEORGE SYNDROME; DISEASE MODEL; DOWN SYNDROME; DUCHENNE MUSCULAR DYSTROPHY; GENE TARGETING; GENETIC ENGINEERING; GENOME; HUMAN; HUMAN GENETICS; ISOCHROMOSOME; LUNG CANCER; MARKER CHROMOSOME; MOUSE; NONHUMAN; PRADER WILLI SYNDROME; REVIEW; RING CHROMOSOME; SMITH MAGENIS SYNDROME; SYNTENY;

ANIMALS; CHROMOSOMES; DISEASE MODELS, ANIMAL; GENE REARRANGEMENT; GENETIC TECHNIQUES; MICE;

EID: 33750331218     PISSN: 15278204     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genom.7.080505.115741     Document Type: Review

References (138)

1. Adams DJ, Biggs PJ, Cox T, Davies R, van der Weyden L, et al. 2004. Mutagenic insertion and chromosome engineering resource (MICER). Nat. Genet. 36:867-71
2. Adams DJ, Dermitzakis ET, Cox T, Smith J, Davies R, et al. 2005. Complex haplotypes, copy number polymorphisms and coding variation in two recently divergent mouse strains. Nat. Genet. 37:532-36
3. Albertson DG, Pinkel D. 2003. Genomic microarrays in human genetic disease and cancer. Hum. Mol. Genet. 12(Spec. No. 2):R145-52
4. Baldini A. 2005. Dissecting contiguous gene defects: TBX1. Curr. Opin. Genet. Dev. 15:279-84
5. Barbouti A, Stankiewicz P, Nusbaum C, Cuomo C, Cook A, et al. 2004. The breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genome architecture with large, palindromic, low-copy repeats. Am. J. Hum. Genet. 74:1-10
6. Benn P. 1998. Trisomy 16 and trisomy 16 Mosaicism: a review. Am. J. Med. Genet. 79:121-33
7. Bergstrom DE, Bergstrom RA, Munroe RJ, Lee BK, Browning VL, et al. 2003. Overlapping deletions spanning the proximal two-thirds of the mouse t complex. Mamm. Genome 14:817-29
8. Betz JL, Behairy AS, Rabionet P, Tirtorahardjo B, Moore MW, Cotter PD. 2005. Acquired inv(9): What is its significance? Cancer Genet. Cytogenet. 160:76-78
9. Bi W, Ohyama T, Nakamara H, Yan J, Visvanathan J, et al. 2005. Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome. Hum. Mol. Genet. 14:983-95
10. Bi W, Yan J, Stankiewicz P, Park SS, Walz K, et al. 2002. Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse. Genome Res. 12:713-28
11. Bi W, Saifi GM, Shaw CJ, Walz K, Fonseca P, et al. 2004. Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome. Hum. Genet. 115:515-24
12. Bondeson ML, Dahl N, Malmgren H, Kleijer WJ, Tonnesen T, et al. 1995. Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome. Hum. Mol. Genet. 4:615-21
13. Brown KW, Watson JE, Poirier V, Mott MG, Berry PJ, Maitland NJ. 1992. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient. Oncogene 7:763-68
14. Buchholz F, Refaeli Y, Trumpp A, Bishop JM. 2000. Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse. EMBO Rep. 1:133-39
15. Buiting K, Saitoh S, Gross S, Dittrich B, Schwartz S, et al. 1995. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat. Genet. 9:395-400
16. Cassidy SB, Schwartz S. 1998. Prader-Willi and Angelman syndromes. Disorders of genomic imprinting. Medicine (Baltimore) 77:140-51
17. Chaplin T, Jones L, Debernardi S, Hill AS, Lillington DM, Young BD. 2001. Molecular analysis of the genomic inversion and insertion of AF10 into MLL suggests a single-step event. Genes Chromosomes Cancer 30:175-80
18. Chen K-S, Mania P, Koeuth T, Potocki L, Zhao Q, et al. 1997. Homologous recombination in between a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nature Genet. 17:154-63
19. Chick WS, Mentzer SE, Carpenter DA, Rinchik EM, You Y. 2004. Modification of an existing chromosomal inversion to engineer a balancer for mouse chromosome 15. Genetics 167:889-95
20. Chung GT, Sundaresan V, Hasleton P, Rudd R, Taylor R, Rabbitts PH. 1995. Sequential molecular genetic changes in lung cancer development. Oncogene 11:2591-98
21. Clayton-Smith J, Pembrey ME. 1992. Angelman syndrome. J. Med. Genet. 29:412-15
22. Collins EC, Pannell R, Simpson EM, Forster A, Rabbitts TH. 2000. Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development. EMBO Rep. 1:127-32
23. Corral J, Lavenir I, Impey H, Warren AJ, Forster A, et al. 1996. An Mll-Af9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 85:853-61
24. Cox GA, Phelps SF, Chapman VM, Chamberlain JS. 1993. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nat. Genet. 4:87-93
25. Daser A, Rabbitts TH. 2004. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev. 18:965-74
26. Davisson MT, Schmidt C, Reeves RH, Irving NG, Akeson EC, et al. 1993. Segmental trisomy as a mouse model for Down syndrome. Prog. Clin. Biol. Res. 384:117-33
27. Davisson MT, Schmidt C, Akeson EC. 1990. Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog. Clin. Biol. Res. 360:263-80
28. de Arce MA, Law E, Martin L, Masterson JG. 1982. A case of inverted insertion assessed by R and G banding. J. Med. Genet. 19:148-51
29. Deeb SS. 2004. Molecular genetics of colour vision deficiencies. Clin. Exp. Optom. 87:224-29
30. Ding F, Prints Y, Dhar MS, Johnson DK, Garnacho-Montero C, et al. 2005. Lack of Pwcr1/MBII-85 snoRNA is critical for neonatal lethality in Prader-Willi syndrome mouse models. Mamm. Genome 16:424-31
31. Dobson CL, Warren AJ, Pannell R, Forster A, Lavenir I, et al. 1999. The Mll-Af9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. EMBO J. 18:3564-74
32. Dobyns WB, Curry CJ, Hoyme HE, Turlington L, Ledbetter DH. 1991. Clinical and molecular diagnosis of Miller-Dieker syndrome. Am. J. Hum. Genet. 48:584-94
33. Driscoll DA, Spinner NB, Budarf ML, McDonald-McGinn DM, Zackai EH, et al. 1992. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am. J. Med. Genet. 44:261-68
34. Drynan LF, Pannell R, Forster A, Chan NM, Cano F, et al. 2005. Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis. EMBO J. 24:3136-46
35. Epstein CJ, Cox DR, Epstein LB. 1985. Mouse trisomy 16: an animal model of human trisomy 21 (Down syndrome). Ann. NY Acad. Sci. 450:157-68
36. Epstein CJ. 1986. Consequences of Chromosome Imbalance: Principals, Mechanisms and Models. New York: Cambridge Univ. Press
37. Fiegler H, Gribble SM, Burford DC, Carr P, Prigmore E, et al. 2003. Array painting: a method for the rapid analysis of aberrant chromosomes using DNA microarrays. J. Med. Genet. 40:664-70
38. Forster A, Pannell R, Drynan LF, McCormack M, Collins EC, et al. 2003. Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer. Cancer Cell 3:449-58
39. Forster A, Pannell R, Drynan LF, Codrington R, Daser A, et al. 2005. The invertor knock-in conditional chromosomal translocation mimic. Nat. Methods 2:27-30
40. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, et al. 1998. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. USA 95:9991-96
41. Greenberg F, Lewis RA, Potocki L, Glaze D, Parke J, et al. 1996. Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2). Am. J. Med. Genet. 62:247-54
42. Gribble SM, Fiegler H, Burford DC, Prigmore E, Yang F, et al. 2004. Applications of combined DNA microarray and chromosome sorting technologies. Chromosome Res. 12:35-43
43. Hentges KE, Justice MJ. 2004. Checks and balancers: balancer chromosomes to facilitate genome annotation. Trends Genet. 20:252-59
44. Herault Y, Rassoulzadegan M, Cuzin F, Duboule D. 1998. Engineering chromosomes in mice through targeted meiotic recombination (TAMERE). Nat. Genet. 20:381-84
45. Higuchi M, O'Brien D, Kumaravelu P, Lenny N, Yeoh EJ, Downing JR. 2002. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 1:63-74
46. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, et al. 1993. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 91:398-402
47. Jerome LA, Papaioannou VE. 2001. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 27:286-91
48. Johnson DK, Stubbs LJ, Culiat CT, Montgomery CS, Russell LB, Rinchik EM. 1995. Molecular analysis of 36 mutations at the mouse pink-eyed dilution (p) locus. Genetics. 141:1563-71
49. Kimber WL, Hsieh P, Hirotsune S, Yuva-Paylor L, Sutherland HF, et al. 1999. Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse. Hum. Mol. Genet. 8:2229-37
50. 47a. Kleinjan DJ, van Heyningen V. 1998. Position effect in human genetic disease. Hum. Mol. Genet. 7:1611-18
51. Klysik J, Dinh C, Bradley A. 2004. Two new mouse chromosome 11 balancers. Genomics 83:303-10
52. Knudson AG Jr. 1971. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68:820-23
53. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. 1987. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509-17
54. Korenberg JR, Chen XN, Schipper R, Sun Z, Gonsky R, et al. 1994. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc. Natl. Acad. Sci. USA 91:4997-5001
55. Korsmeyer SJ. 1992. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu. Rev. Immunol. 10:785-807
56. Kudoh H, Ikeda H, Kakitani M, Ueda A, Hayasaka M, et al. 2005. A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system. Biochem. Biophys. Res. Commun. 328:507-16
57. Lakich D, Kazazian HH Jr, Antonarakis SE, Gitschier J. 1993. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat. Genet. 5:236-41
58. Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM, Rowley JD. 1983. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic- clinicopathological association. N. Engl. J. Med. 309:630-36
59. Lerman MI, Minna JD. 2000. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 60:6116-33
60. Lewis SE, Barnett LB, Akeson EC, Davisson MT. 1990. A new dominant neurological mutant induced in the mouse by ethylene oxide. Mutat. Res. 229:135-39
61. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, et al. 1992. A chimaeric 11 β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262-65
62. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, et al. 2001. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410:97-101
63. Lindsay EA, Botta A, Jurecic V, Carattini-Rivera S, Cheah YC, et al. 1999. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401:379-83
64. Lindsay EA. 2001. Chromosomal microdeletions: dissecting del22q11 syndrome. Nat. Rev. Genet. 2:858-68
65. Liu PP, Hajra A, Wijmenga C, Collins FS. 1995. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 85:2289-302
66. Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, et al. 1993. Fusion between transcription factor CBF β/PEBP2 β and a myosin heavy chain in acute myeloid leukemia. Science 261:1041-44
67. Ludecke HJ, Johnson C, Wagner MJ, Wells DE, Turleau C, et al. 1991. Molecular definition of the shortest region of deletion overlap in the Langer-Giedion syndrome. Am. J. Hum. Genet. 49:1197-206
68. Lund J, Roe B, Chen F, Budarf M, Galili N, et al. 1999. Sequence-ready physical map of the mouse chromosome 16 region with conserved synteny to the human velocardiofacial syndrome region on 22q11.2. Mamm. Genome 10:438-43
69. Lupski JR. 1998. Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends. Genet. 14:417-22
70. Maitra A, Wistuba, II, Washington C, Virmani AK, Ashfaq R, et al. 2001. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am. J. Pathol. 159:119-30
71. McCormick MK, Schinzel A, Petersen MB, Stetten G, Driscoll DJ, et al. 1989. Molecular genetic approach to the characterization of the "Down syndrome region" of chromosome 21. Genomics 5:325-31
72. Merscher S, Funke B, Epstein JA, Heyer J, Puech A, et al. 2001. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104:619-29
73. Mertens F, Johansson B, Mitelman F. 1994. Isochromosomes in neoplasia. Genes Chromosomes Cancer 10:221-30
74. Mills AA, Bradley A. 2001. From mouse to man: generating megabase chromosome rearrangements. Trends Genet. 17:331-39
75. Muntoni F, Torelli S, Ferlini A. 2003. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol. 2:731-40
76. Nicholls RD, Knepper JL. 2001. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics Hum. Genet. 2:153-75
77. Nicholls RD, Saitoh S, Horsthemke B. 1998. Imprinting in Prader-Willi and Angelman syndromes. Trends Genet. 14:194-200
78. Nishijima I, Mills A, Qi Y, Mills M, Bradley A. 2003. Two new balancer chromosomes on mouse chromosome 4 to facilitate functional annotation of human chromosome 1p. Genesis 36:142-48
79. Nucifora G, Rowley JD. 1994. The AML1 and ETO genes in acute myeloid leukemia with a t(8;21). Leuk. Lymphoma 14:353-62
80. O'Doherty A, Ruf S, Mulligan C, Hildreth V, Errington ML, et al. 2005. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 309:2033-37
81. Okuda T, Cai Z, Yang S, Lenny N, Lyu CJ, et al. 1998. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood 91:3134-43
82. Olson LE, Roper RJ, Baxter LL, Carlson EJ, Epstein CJ, Reeves RH. 2004. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Dev. Dyn. 230:581-89
83. Olson LE, Richtsmeier JT, Leszl J, Reeves RH. 2004. A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science 306:687-90
84. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J. Clin. 55:74-108
85. Philipp-Staheli J, Payne SR, Kemp CJ. 2001. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp. Cell. Res. 264:148-68
86. Potocki L, Chen KS, Park SS, Osterholm DE, Withers MA, et al. 2000. Molecular mechanism for duplication 17 p11.2 - the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat. Genet. 24:84-87
87. Potter M, Wiener F. 1992. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis 13:1681-97
88. Puech A, Saint-Jore B, Merscher S, Russell RG, Cherif D, et al. 2000. Normal cardiovascular development in mice deficient for 16 genes in 550 kb of the velocardiofacial/DiGeorge syndrome region. Proc. Natl. Acad. Sci. USA 97:10090-95
89. Rabbitts TH. 1994. Chromosomal translocations in human cancer. Nature 372:143-49
90. Ramirez-Solis R, Liu P, Bradley A. 1995. Chromosome engineering in mice. Nature 378:720-24
91. Randolph TR. 2005. Chronic myelocytic leukemia-Part I: History, clinical presentation, and molecular biology. Clin. Lab. Sci. 18:38-48
92. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, et al. 1995. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat. Genet. 11:177-84
93. Reeves RH, Citron MP. 1994. Mouse chromosome 16. Mamm. Genome 5(Spec. No.):S229-37
94. Reis A, Dittrich B, Greger V, Buiting K, Lalande M, et al. 1994. Imprinting mutations suggested by abnormal DNA methylation patterns in familial Angelman and Prader-Willi syndromes. Am. J. Hum. Genet. 54:741-47
95. Richtsmeier JT, Baxter LL, Reeves RH. 2000. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev. Dyn. 217:137-45
96. Roa BB, Garcia CA, Lupski JR. 1991-1992. Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy. Int. J. Neurol. 25-26:97-107
97. Roderick TH, Hawes NL. 1974. Nineteen paracentric chromosomal inversions in mice. Genetics 76:109-17
98. Roderick TH, Hawes NL. 1970. Two radiation-induced chromosomal inversions in mice (Mus musculus). Proc. Natl. Acad. Sci. USA 67:961-67
99. Russell LB, Hunsicker PR, Cacheiro NL, Bangham JW, Russell WL, Shelby MD. 1989. Chlorambucil effectively induces deletion mutations in mouse germ cells. Proc. Natl. Acad. Sci. USA 86:3704-8
100. Sago H, Carlson EJ, Smith DJ, Kilbridge J, Rubin EM, et al. 1998. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc. Natl. Acad. Sci. USA 95:6256-61
101. Sago H, Carlson EJ, Smith DJ, Rubin EM, Crnic LS, et al. 2000. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr. Res. 48:606-13
102. Saitoh S, Buiting K, Rogan PK, Buxton JL, Driscoll DJ, et al. 1996. Minimal definition of the imprinting center and fixation of chromosome 15q11-q13 epigenotype by imprinting mutations. Proc. Natl. Acad. Sci. USA 93:7811-15
103. Scambler PJ, Carey AH, Wyse RK, Roach S, Dumanski JP, et al. 1991. Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics 10:201-6
104. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, et al. 2004. Large-scale copy number polymorphism in the human genome. Science 305:525-28
105. Sekido Y, Ahmadian M, Wistuba, II, Latif F, Bader S, et al. 1998. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene 16:3151-57
106. Shaffer LJ, Lupski JR. 2000. Molecular mechanisms for constitutional chromosomal rearrangements in humans. Annu. Rev. Genet. 34:297-329
107. Shapiro BL. 1999. The Down syndrome critical region. J. Neural. Transm. Suppl. 57:41-60
108. Deleted in proof
109. Shaw CJ, Lupski JR. 2004. Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. Hum. Mol. Genet. 13(Spec. No. 1):R57-64
110. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ. 1989. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244:1578-80
111. Slager RE, Newton TL, Vlangos CN, Finucane B, Elsea SH. 2003. Mutations in RAI1 associated with Smith-Magenis syndrome. Nat. Genet. 33:466-68
112. Smith AJ, De Sousa MA, Kwabi-Addo B, Heppell-Parton A, Impey H, Rabbitts P. 1995. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Nat. Genet. 9:376-85
113. Smith AJ, Xian J, Richardson M, Johnstone KA, Rabbitts PH. 2002. Cre-loxP chromosome engineering of a targeted deletion in the mouse corresponding to the 3p21.3 region of homozygous loss in human tumours. Oncogene 21:4521-29
114. Starke H, Nietzel A, Weise A, Heller A, Mrasek K, et al. 2003. Small supernumerary marker chromosomes (SMCs): genotype-phenotype correlation and classification. Hum. Genet. 114:51-67
115. Stubbs L, Carver EA, Cacheiro NL, Shelby M, Generoso W. 1997. Generation and characterization of heritable reciprocal translocations in mice. Methods 13:397-408
116. Su H, Wang X, Bradley A. 2000. Nested chromosomal deletions induced with retroviral vectors in mice. Nat. Genet. 24:92-95
117. Sutcliffe JS, Nakao M, Christian S, Orstavik KH, Tommerup N, et al. 1994. Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat. Genet. 8:52-58
118. Sykes PJ, Hooker AM, Harrington CS, Jacobs AK, Kingsbury L, Morley AA. 1998. Induction of somatic intrachromosomal recombination inversion events by cyclophosphamide in a transgenic mouse model. Mutat. Res. 397:209-19
119. Thomas JW, LaMantia C, Magnuson T. 1998. X-ray-induced mutations in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 95:1114-19
120. Timms KM, Bondeson ML, Ansari-Lari MA, Lagerstedt K, Muzny DM, et al. 1997. Molecular and phenotypic variation in patients with severe Hunter syndrome. Hum. Mol. Genet. 6:479-86
121. Tsai TF, Jiang YH, Bressler J, Armstrong D, Beaudet AL. 1999. Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader-Willi syndrome. Hum. Mol. Genet. 8:1357-64
122. van der Weyden L, Tachibana KK, Gonzalez MA, Adams DJ, Ng BL, et al. 2005. The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol. Cell. Biol. 25:8356-67
123. Van Deursen J, Fornerod M, Van Rees B, Grosveld G. 1995. Cre-mediated site-specific translocation between nonhomologous mouse chromosomes. Proc. Natl. Acad. Sci. USA 92:7376-80
124. Vlangos CN, Yim DK, Elsea SH. 2003. Refinement of the Smith-Magenis syndrome critical region to approximately 950kb and assessment of 17p11.2 deletions. Are all deletions created equally? Mol. Genet. Metab. 79:134-41
125. von Lindern M, Poustka A, Lerach H, Grosveld G. 1990. The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34. Mol. Cell. Biol. 10:4016-26
126. Walz K, Caratini-Rivera S, Bi W, Fonseca P, Mansouri DL, et al. 2003. Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) contiguous gene syndromes by chromosome engineering in mice: phenotypic consequences of gene dosage imbalance. Mol. Cell. Biol. 23:3646-55
127. Walz K, Spencer C, Kaasik K, Lee CC, Lupski JR, Paylor R. 2004. Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2). Hum. Mol. Genet. 13:367-78
128. Wertz K, Fuchtbauer EM. 1998. Dmd(mdx-β geo): a new allele for the mouse dystrophin gene. Dev. Dyn. 212:229-41
129. Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, et al. 2000. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 60:1949-60
130. Yan J, Keener VW, Bi W, Walz K, Bradley A, et al. 2004. Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome. Hum. Mol. Genet. 13:2613-24
131. Yan J, Walz K, Nakamura H, Carattini-Rivera S, Zhao Q, et al. 2003. COP9 signalosome subunit 3 (cn3) is essential for maintenance of cell proliferation in the mouse embryonic epiblast. Mol. Cell. Biol. 23:6798-808
132. Yang T, Adamson TE, Resnick JL, Leff S, Wevrick R, et al. 1998. A mouse model for Prader-Willi syndrome imprinting-centre mutations. Nat. Genet. 19:25-31
133. Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, et al. 1997. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet. 15:303-6
134. You Y, Bergstrom R, Klemm M, Lederman B, Nelson H, et al. 1997. Chromosomal deletion complexes in mice by radiation of embryonic stem cells. Nat. Genet. 15:285-88
135. Yu Y, Bradley A. 2001. Engineering chromosomal rearrangements in mice. Nat. Rev. Genet. 2:780-90
136. Zheng B, Mills AA, Bradley A. 1999. A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice. Nucleic Acids Res. 27:2354-60
137. Zheng B, Sage M, Cai WW, Thompson DM, Tavsanli BC, et al. 1999. Engineering a mouse balancer chromosome. Nat. Genet. 22:375-78
138. Sharp AJ, Cheng Z, Eichler E. 2006. Structural variation of the human genome. Annu. Rev. Genomics Hum. Genet. 7:407-42